Electron crystallography of human blood coagulation factor VIII bound to phospholipid monolayers

Svetla S. Stoylova, Peter J. Lenting, Geoffrey Kemball-Cook, Andreas Holzenburg

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Coagulation factor VIII binds to negatively charged platelets prior to assembly with the serine protease, factor IXa, to form the factor X- activating enzyme (FXase) complex. The macromolecular organization of membrane-bound factor VIII has been studied by electron crystallography for the first time. For this purpose two-dimensional crystals of human factor VIII were grown onto phosphatidylserine-containing phospholipid monolayers, under near to physiological conditions (pH and salt concentration). Electron crystallographic analysis revealed that the factor VIII molecules were organized as monomers onto the lipid layer, with unit cell dimensions: a = 81.5Å, b = 67.2 Å, γ = 66.5°, P1 symmetry. Based on a homology-derived molecular model of the factor VIII (FVIII) A domains, the HI projection structure solved at 15-Å resolution presents the A1, A2, and A3 domain heterotrimer tilted approximately 65°relative to the membrane plane. The A1 domain is projecting on top of the A3, C1, and C2 domains and with the A2 domain protruding partially between A1 and A3. This organization of factor VIII allows the factor IXa protease and epidermal growth factor-like domain binding sites (localized in the A2 and A3 domains, respectively) to be situated at the appropriate position for the binding of factor IXa. The conformation of the lipid-bound FVIII is therefore very close to that for the activated factor VIIIa predicted in the FX-ase complex.

Original languageEnglish (US)
Pages (from-to)36573-36578
Number of pages6
JournalJournal of Biological Chemistry
Volume274
Issue number51
DOIs
StatePublished - Dec 17 1999
Externally publishedYes

Fingerprint

Crystallography
Factor VIII
Monolayers
Phospholipids
Factor IXa
Electrons
varespladib methyl
cancer procoagulant
Factor VIIIa
Membranes
Lipids
Factor X
Molecular Models
Phosphatidylserines
Serine Proteases
Platelets
Epidermal Growth Factor
Conformations
Peptide Hydrolases
Blood Platelets

ASJC Scopus subject areas

  • Biochemistry

Cite this

Electron crystallography of human blood coagulation factor VIII bound to phospholipid monolayers. / Stoylova, Svetla S.; Lenting, Peter J.; Kemball-Cook, Geoffrey; Holzenburg, Andreas.

In: Journal of Biological Chemistry, Vol. 274, No. 51, 17.12.1999, p. 36573-36578.

Research output: Contribution to journalArticle

Stoylova, Svetla S. ; Lenting, Peter J. ; Kemball-Cook, Geoffrey ; Holzenburg, Andreas. / Electron crystallography of human blood coagulation factor VIII bound to phospholipid monolayers. In: Journal of Biological Chemistry. 1999 ; Vol. 274, No. 51. pp. 36573-36578.
@article{1fa048af12e542e2a8853ecdcb57b44e,
title = "Electron crystallography of human blood coagulation factor VIII bound to phospholipid monolayers",
abstract = "Coagulation factor VIII binds to negatively charged platelets prior to assembly with the serine protease, factor IXa, to form the factor X- activating enzyme (FXase) complex. The macromolecular organization of membrane-bound factor VIII has been studied by electron crystallography for the first time. For this purpose two-dimensional crystals of human factor VIII were grown onto phosphatidylserine-containing phospholipid monolayers, under near to physiological conditions (pH and salt concentration). Electron crystallographic analysis revealed that the factor VIII molecules were organized as monomers onto the lipid layer, with unit cell dimensions: a = 81.5{\AA}, b = 67.2 {\AA}, γ = 66.5°, P1 symmetry. Based on a homology-derived molecular model of the factor VIII (FVIII) A domains, the HI projection structure solved at 15-{\AA} resolution presents the A1, A2, and A3 domain heterotrimer tilted approximately 65°relative to the membrane plane. The A1 domain is projecting on top of the A3, C1, and C2 domains and with the A2 domain protruding partially between A1 and A3. This organization of factor VIII allows the factor IXa protease and epidermal growth factor-like domain binding sites (localized in the A2 and A3 domains, respectively) to be situated at the appropriate position for the binding of factor IXa. The conformation of the lipid-bound FVIII is therefore very close to that for the activated factor VIIIa predicted in the FX-ase complex.",
author = "Stoylova, {Svetla S.} and Lenting, {Peter J.} and Geoffrey Kemball-Cook and Andreas Holzenburg",
year = "1999",
month = "12",
day = "17",
doi = "10.1074/jbc.274.51.36573",
language = "English (US)",
volume = "274",
pages = "36573--36578",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "51",

}

TY - JOUR

T1 - Electron crystallography of human blood coagulation factor VIII bound to phospholipid monolayers

AU - Stoylova, Svetla S.

AU - Lenting, Peter J.

AU - Kemball-Cook, Geoffrey

AU - Holzenburg, Andreas

PY - 1999/12/17

Y1 - 1999/12/17

N2 - Coagulation factor VIII binds to negatively charged platelets prior to assembly with the serine protease, factor IXa, to form the factor X- activating enzyme (FXase) complex. The macromolecular organization of membrane-bound factor VIII has been studied by electron crystallography for the first time. For this purpose two-dimensional crystals of human factor VIII were grown onto phosphatidylserine-containing phospholipid monolayers, under near to physiological conditions (pH and salt concentration). Electron crystallographic analysis revealed that the factor VIII molecules were organized as monomers onto the lipid layer, with unit cell dimensions: a = 81.5Å, b = 67.2 Å, γ = 66.5°, P1 symmetry. Based on a homology-derived molecular model of the factor VIII (FVIII) A domains, the HI projection structure solved at 15-Å resolution presents the A1, A2, and A3 domain heterotrimer tilted approximately 65°relative to the membrane plane. The A1 domain is projecting on top of the A3, C1, and C2 domains and with the A2 domain protruding partially between A1 and A3. This organization of factor VIII allows the factor IXa protease and epidermal growth factor-like domain binding sites (localized in the A2 and A3 domains, respectively) to be situated at the appropriate position for the binding of factor IXa. The conformation of the lipid-bound FVIII is therefore very close to that for the activated factor VIIIa predicted in the FX-ase complex.

AB - Coagulation factor VIII binds to negatively charged platelets prior to assembly with the serine protease, factor IXa, to form the factor X- activating enzyme (FXase) complex. The macromolecular organization of membrane-bound factor VIII has been studied by electron crystallography for the first time. For this purpose two-dimensional crystals of human factor VIII were grown onto phosphatidylserine-containing phospholipid monolayers, under near to physiological conditions (pH and salt concentration). Electron crystallographic analysis revealed that the factor VIII molecules were organized as monomers onto the lipid layer, with unit cell dimensions: a = 81.5Å, b = 67.2 Å, γ = 66.5°, P1 symmetry. Based on a homology-derived molecular model of the factor VIII (FVIII) A domains, the HI projection structure solved at 15-Å resolution presents the A1, A2, and A3 domain heterotrimer tilted approximately 65°relative to the membrane plane. The A1 domain is projecting on top of the A3, C1, and C2 domains and with the A2 domain protruding partially between A1 and A3. This organization of factor VIII allows the factor IXa protease and epidermal growth factor-like domain binding sites (localized in the A2 and A3 domains, respectively) to be situated at the appropriate position for the binding of factor IXa. The conformation of the lipid-bound FVIII is therefore very close to that for the activated factor VIIIa predicted in the FX-ase complex.

UR - http://www.scopus.com/inward/record.url?scp=0033579442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033579442&partnerID=8YFLogxK

U2 - 10.1074/jbc.274.51.36573

DO - 10.1074/jbc.274.51.36573

M3 - Article

C2 - 10593957

AN - SCOPUS:0033579442

VL - 274

SP - 36573

EP - 36578

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 51

ER -